Intacept 50mg Injection 1’s
₹10,390.00
Attributes
- Is Prescription Required
- Yes
- Is Returnable
- No
- Type
- Pharma
- Consume Type
- Parenteral
- Pack Size
- 1
- Cold Chain Product
- Yes
- Banned
- No
- Marketer Address
- Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.
- Pack Form
- Vial
- Product Form
- Injection
- Unit Of Measurement
- ml
- Subcategory
- C.N.S Drugs
- Manufacturer
- Intas Pharmaceuticals Ltd
- Country Of Origin
- India
- Classifier 1
- IMMUNO MODULATORS
- Classifier 2
- AUTO IMMUNE DISORDERS
- Classifier 3
- IMMUNO SUPPRESSANTS
- Restricted
- Yes
- Is Sensitive
- Yes
- Dosage Forms
- Injection
- Short Name
- Intacept 50mg Injection
- Unitprice
- ₹8312 / 1 ml
- Dpco Drug
- No
Description
Key Benefits
Intacept 50mg Injection 1’s consists of Etanercept, which belongs to TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce pain, redness, and inflammation (swelling) in patients with rheumatoid arthritis, ankylosing spondylitis, and other autoimmune disorders.
Directions for Use
Intacept 50mg Injection 1’s will be administered by a healthcare professional. Do not self-administer.
Side Effects
- Tingling or numbness
- Dizziness
- Shortness of breath
- Bleeding
- Bruising
- Vision problem
- Redness on the skin and arms
- Injection site reactions
Storage
Store in a cool and dry place away from sunlight
Additional information
| Is Prescription Required | |
|---|---|
| Is Returnable | |
| Type | |
| Consume Type | |
| Pack Size | |
| Cold Chain Product | |
| Banned | |
| Marketer Address | Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India. |
| Pack Form | |
| Product Form | |
| Unit Of Measurement | |
| Subcategory | |
| Manufacturer | |
| Country Of Origin | |
| Classifier 1 | |
| Classifier 2 | |
| Classifier 3 | |
| Restricted | |
| Is Sensitive | |
| Dosage Forms | |
| Short Name | |
| Unitprice | |
| Dpco Drug |
